We have previously demonstrated that knockout of the calcineurin gene or inhibition of calcineurin activity by immunosuppressants resulted in hypersensitivity to Cl ؊ in fission yeast. We also demonstrated that knockout of the components of the Pmk1 mitogen-activated protein kinase (MAPK) pathway, such as Pmk1 or Pek1 complemented the hypersensitivity to Cl ؊ . Using this interaction between calcineurin and Pmk1 MAPK, here we developed a genetic screen that aims to identify new regulators of the Pmk1 signaling and isolated vic (viable in the presence of immunosuppressant and chloride ion) mutants. One of the mutants, vic1-1, carried a missense mutation in the cpp1 ؉ gene encoding a ␤ subunit of the protein farnesyltransferase, which caused an amino acid substitution of aspartate 155 of Cpp1 to asparagine (Cpp1 D155N ). Analysis of the mutant strain revealed that Rho2 is a novel target of Cpp1. Moreover, Cpp1 and Rho2 act upstream of Pck2-Pmk1 MAPK signaling pathway, thereby resulting in the vic phenotype upon their mutations. Interestingly, compared with other substrates of Cpp1, defects of Rho2 function were more phenotypically manifested by the Cpp1 D155N mutation. Together, our results demonstrate that Cpp1 is a key component of the Pck2-Pmk1 signaling through the spatial control of the small GTPase Rho2.
INTRODUCTION
The mitogen-activated protein kinase (MAPK) pathway is one of the most important intracellular signaling that plays a crucial role in cell proliferation, cell differentiation, and cell cycle regulation (Nishida and Gotoh, 1993; Marshall, 1994; Herskowitz, 1995; Levin and Errede, 1995) . The Pmk1 MAPK, a homologue of the mammalian extracellular signalregulated kinase (ERK)/MAPK, regulates cell morphology and cell integrity in fission yeast Schizosaccharomyces pombe (Toda et al., 1996; Zaitsevskaya-Carter and Cooper, 1997) . A functional connection between the Pmk1 pathway and the protein kinase C homologues Pck1 and Pck2 has been suggested, and differential roles of Pck1 and Pck2 in the regulation of cell integrity also have been suggested; however, it is unclear whether these protein kinase C homologues act upstream of the Pmk1 pathway or synergistically regulate independent aspects of cell integrity (Toda et al., 1996; Sengar et al., 1997; Arellano et al., 1999; Calonge et al., 2000) .
We have previously demonstrated that knockout of the fission yeast calcineurin gene ppb1 ϩ or inhibition of calcineurin activity by immunosuppressants results in hypersensitivity to Cl Ϫ , and that calcineurin and Pmk1 MAPK play antagonistic roles in Cl Ϫ homeostasis (Sugiura et al., 1998) . Based on this genetic interaction between calcineurin and Pmk1 MAPK, we screened for multicopy suppressors of the Cl Ϫ -hypersensitive phenotype of the calcineurin knockout and identified genes encoding an MAPK phosphatase Pmp1 (Sugiura et al., 1998) ; MAPK kinase (MAPKK) Pek1 (Sugiura et al., 1999) , and a novel KH-type RNA-binding protein Rnc1 that binds and stabilizes Pmp1 mRNA (Sugiura et al., 2003) .
We also demonstrated that knockout of the components of the Pmk1 MAPK pathway, such as Pmk1 or Pek1 complemented the Cl Ϫ -hypersensitive phenotype of calcineurin knockout. Notably, these knockout strains are viable in the presence of immunosuppressant FK506 and high concentrations of MgCl 2 , whereas the wild-type cells are inviable in the same condition (Sugiura et al., 1998 (Sugiura et al., , 1999 . These results prompted us to perform a novel genetic screen to isolate vic (viable in the presence of immunosuppressant and chloride ion) mutants, aiming to identify novel components of the Pmk1 MAPK pathway.
We have identified a vic1-1/cpp1-v1 mutant, in addition to the mutation allele in the known components of the Pmk1 MAPK pathway, including pmk1 ϩ (MAPK), pek1 ϩ (MAPKK), mkh1 ϩ (MAPKK kinase, MAPKKK) as well as pck2 ϩ (protein kinase C). The cpp1 ϩ gene encodes a ␤ subunit of the farnesyltransferase (FTase) that is highly conserved through evolution.
In mammals, many proteins, including Ras family small GTPases, nuclear lamins A and B, transducin, rhodopsin kinase, and a peroxisomal protein termed PxF, have been reported as substrates for FTase (Glomset and Farnsworth, 1994; Zhang and Casey, 1996; Casey and Seabra, 1996; Gelb, 1997; Mumby, 1997) . There is widespread interest in FTase because Ras proteins are modified by FTase and such a modification is critical for the oncogenic transformation (Hancock et al., 1989; Jackson et al., 1990; Kato et al., 1992) .
Several FTase inhibitors (FTIs) have been in clinical trials for the treatment of cancer (Johnston, 2001; Ayral-Kaloustian and Salaski, 2002) . Also, recent studies have reported that abnormal persistence of the farnesyl modifications on the nuclear prelamin A has been implicated in the pathogenesis of Hutchinson-Gilford progeria syndrome, a devastating premature aging disease (Pollex and Hegele, 2004) . Thus, FTIs represent a possible therapeutic option for cancer as well as for individuals with Hutchinson-Gilford progeria syndrome.
In budding yeast Saccharomyces cerevisiae, ␣-factor mating pheromone and Ras2 involved in the cAMP pathway have been identified as substrates of FTase (Goodman et al., 1990; He et al., 1991) . In fission yeast Schizosaccharomyces pombe, FTase Cpp1 has been reported to play a critical role in sexual differentiation and morphogenesis through Ras1 (Yang et al., 2000) and also has been reported to play a role in cell cycle progression through Rheb (Yang et al., 2001) .
Here, we show that the small GTPase Rho2 is a novel target of Cpp1 and that Cpp1 and Rho2 act upstream of Pck2-Pmk1 MAPK cell integrity signaling pathway.
MATERIALS AND METHODS

Strains, Media, and Genetic and Molecular Biology Methods
The S. pombe strains used in this study are listed in Table 1 . The complete medium yeast extract-peptone-dextrose (YPD) and the minimal medium Edinburgh minimal medium (EMM) have been described previously (Toda et al., 1996) . Standard genetic and recombinant DNA methods (Moreno et al., 1991) were used except where noted. FK506 was provided by Fujisawa Pharmaceutical Co. (Osaka, Japan).
Isolation of vic1-1/cpp1-v1 Mutant
The vic1-1/cpp1-v1 mutant was isolated in a screen of cells that had been mutagenized with nitrosoguanidine as described previously (Zhang et al., 2000) . Mutants were spread on YPD plates to give ϳ1000 cells/plate, and the plates were incubated at 27°C for 4 d. The plates were then replica-plated at 27°C onto plates containing 0.5 g/ml FK506 and 0.2 M MgCl 2 . Mutants that grew in the plates were selected and designated as vic mutants. The original mutants isolated were backcrossed three times to wild-type strains HM123 and HM528.
Cloning and Knockout of the cpp1
؉ Gene
To clone the vic1 ϩ gene, the temperature sensitivity of vic1-1 mutants (KP754) was used. The vic1-1 mutants were grown at 27°C and transformed with an S. pombe genomic DNA library constructed in the vector pDB248 (Beach et al., 1982) . Leu ϩ transformants were replica-plated onto YPD plates at 36°C, and the plasmid DNA was recovered from transformants that showed plasmiddependent rescue. These plasmids complemented both the temperature sensitivity and vic phenotype of the vic1-1 mutant. By DNA sequencing, the suppressing plasmids were identified to contain the cpp1 ϩ gene (SPAC17G6.04c). To investigate the relationship between the cloned cpp1 ϩ gene and vic1-1 mutant, linkage analysis was performed as follows. The entire cpp1 ϩ gene was subcloned into the pUC-derived plasmid containing S. cerevisiae LEU2 gene and integrated by homologous recombination into the genome of the wild-type strain HM123. The integrant was mated with the vic1-1 mutant. The resulting diploid was sporulated, and tetrads were dissected. In total, 30 tetrads were dissected. In all cases, only parental ditype tetrads were found, indicating allelism between the cpp1 ϩ gene and the vic1-1 mutation (our unpublished data).
To knockout cpp1 ϩ gene, a one-step gene disruption by homologous recombination was performed as described previously (Rothstein, 1983) . The cpp1::ura4 ϩ disruption was constructed as follows. The BamHI fragment containing the cpp1 ϩ gene was subcloned into the BamHI site of BlueScriptSK(ϩ) (Stratagene, La Jolla, CA). Then, a PstI/SmaI fragment containing the ura4 ϩ gene was inserted into the NsiI/EcoRV site of the previous construct. The fragment containing the disrupted cpp1 ϩ gene was transformed into haploid cells. Stable integrants were selected on medium lacking uracil, and knockout of the gene was checked by genomic Southern hybridization and tetrad analysis (our unpublished data).
Cloning and Tagging of the rho1
؉ , rho2 ؉ , rho3 ؉ , and ras1
؉ Genes
The rho1 ϩ , rho2 ϩ , rho3 ϩ , and ras1 ϩ genes were amplified by PCR with the genomic DNA of wild-type cells as a template. The primers used were summarized in Table 2 . The amplified products containing theses genes were digested with BamHI, and the resulting fragments were subcloned into BlueScriptSK(ϩ).
For ectopic expression of proteins, we used the thiamine-repressible nmt1 promoter (Maundrell, 1993) . Expression was repressed by the addition of 4 M thiamine to EMM and was induced by washing and then incubating the cells in EMM lacking thiamine. To express green fluorescent protein (GFP)-Rho1, Rho2, Rho3, or Ras1, these genes were tagged at its N terminus with This study GFP carrying the S65T mutation. Rho2CIIL and Rho2SIIS were made in the same way except that the antisense primers were specifically designed for amplifying Rho2CIIL and Rho2SIIS. Similarly, Rho2, Ras1, or Rho3 was tagged at its N terminus with FLAG. These constructs were confirmed to be fully functional as their expression complemented the phenotypes associated with ⌬ras1, ⌬rho2, and ⌬rho3, respectively (our unpublished data).
Microscopy and Miscellaneous Methods
Methods in light microscopy, such as fluorescence microscopy and differential interference contrast microscopy, were performed as described previously (Kita et al., 2004) . Cell extract preparation and immunoblot analysis were performed as described previously (Sio et al., 2005) .
RESULTS
Isolation of vic Mutants
To identify new components of the protein kinase C-Pmk1 MAPK signaling pathway, we performed a genetic screen in S. pombe based on the functional interaction that calcineurin and Pmk1 MAPK play antagonistic roles in Cl Ϫ homeostasis (Sugiura et al., 1998) . On inhibition of the Pmk1 MAPK signaling, the Cl Ϫ -hypersensitive phenotype of calcineurin knockout was complemented, i.e., the knockout of pmk1 ϩ , pek1 ϩ , mkh1 ϩ , or pck2 ϩ all complemented the Cl Ϫ -hypersensitive phenotype of calcineurin knockout ( Figure 1A , ϩ0.2 M MgCl 2 ). The inhibition of calcineurin signaling is also achieved by the immunosuppressant FK506, a specific inhibitor of calcineurin, because wild-type cells failed to grow in the presence of FK506 and 0.2 M MgCl 2 ( Figure 1A , wt, ϩFK506 ϩ 0.2 M MgCl 2 ). Consistently, knockout of the components of protein kinase C-MAPK signaling makes cells grow in the presence of FK506 and MgCl 2 ( Figure 1A , ϩFK506 ϩ 0.2 M MgCl 2 ). We therefore hypothesized that if we isolate mutants that can grow in the presence of FK506 and 0.2 M MgCl 2 , the genes responsible for the mutation are expected to function in the protein kinase C-Pmk1 MAPK signaling. These may include mutations in the unknown factor downstream of Pmk1 or in novel factors required for the activation or function of Pmk1 MAPK. We then performed the isolation of the mutants that are viable in the presence of immunosuppressant and chloride ion; hence, we named these as vic mutants. By this genetic approach, we isolated several novel mutants, in addition to mkh1, pek1, pmk1, and pck2 mutants (our unpublished data). Here, we focus on the characterization of the vic1-1 mutant.
As shown in Figure EMM 36°C). As predicted, the vic1-1⌬ppb1 double mutant cells were able to grow in the presence of 0.2 M MgCl 2 (our unpublished data), indicating that the vic1-1 mutation suppresses the Cl Ϫ sensitivity of calcineurin knockout and suggesting that the gene product is involved in the regulation of the Pmk1 MAPK pathway. ϩ gene and the vic1-1 mutation. We therefore renamed vic1-1 as cpp1-v1.
To identify the mutation site in the cpp1-v1 allele, the genomic DNA from cpp1-v1 mutant cells was isolated, and the full-length coding region of the cpp1-v1 gene was sequenced. The G-to-A nucleotide substitution caused a highly conserved aspartic acid to be altered to an asparagine residue at the amino acid position 155 ( Figure 1C, black arrow) . We therefore refer to the protein product of the cpp1-v1 gene as Cpp1 D155N . We constructed Cpp1 knockout (see Materials and Methods) , and ⌬cpp1 cells displayed a slow growth rate even at the permissive temperature of 27°C as reported by Yang et al. (2000) . In contrast, cpp1-v1 mutant cells grew normally at the permissive temperature of 27°C ( Figure 1D, YPD 27°C) . The ⌬cpp1 cells also grew in the presence of FK506 and 0.2 M MgCl 2 ; however, the growth rate was significantly slower compared with that of the cpp1-v1 mutant cells ( Figure 1D , ϩ FK506 ϩ 0.2 M MgCl 2 ). Thus, in contrast to the cpp1-v1 mutant cells, the ⌬cpp1 cells did not display a markedly clear vic phenotype. Notably, the degree of the temperature-sensitive growth defect was more severe in ⌬cpp1 cells, because ⌬cpp1 cells failed to grow even at 33°C, whereas cpp1-v1 mutant cells grew well ( Figure 1D, YPD 33°C) . Thus, the cpp1-v1 mutant and ⌬cpp1 cells displayed similar but distinct phenotypes, suggesting that FTase activity is partially deficient in cpp1-v1 mutant cells. Consistently, overexpression of Cpp1 D155N suppressed the temperature-sensitive phenotype of ⌬cpp1 cells (our unpublished data).
Rho2 Is the Target of Cpp1 Responsible for vic Phenotype
FTase catalyzes the posttranslational modification of Ras and other Ras family proteins. The target proteins have a consensus CAAX motif (where C represents cysteine, A represents aliphatic amino acid, and X preferentially represents methionine, cysteine, serine, alanine, or glutamine) at the C terminus (Maltese, 1990; Cox and Der, 1992; Magee et al., 1992) .
In fission yeast, Ras1 (a known target of Cpp1), Rho2, and Rho3 small GTPases contain CAAX motif modified by FTase (Figure 2A, FTase) , and Rho1 small GTPase contains CAAL motif modified by geranylgeranyltransferase I (Figure 2A , GGTase I). We examined the intracellular localization of Ras1, Rho2, Rho3, and Rho1 in wild-type, cpp1-v1 mutant, or ⌬cpp1 cells, based on the assumption that a mutation in the cpp1 ϩ gene should cause a defect in the farnesylation of the target small GTPases, thereby leading to a defect in their intracellular localization.
As shown in Figure 2B , in wild-type cells all these small GTPases predominantly localized to the plasma membrane. However, in cpp1-v1 mutant cells and ⌬cpp1 cells, the plasma membrane localization of Ras1 or Rho2 was not clearly observed. In contrast, in cpp1-v1 mutant cells the plasma membrane localization of Rho3 was clearly observed, and in ⌬cpp1 cells it was abolished. Note that the localization of CAAL-ending GTPase Rho1 was not affected in either cpp1-v1 mutant or ⌬cpp1 cells. ⌬cpp1 cells displayed the round cell shape as reported previously owing to the defective farnesylation of Ras1 (Yang et al., 2000 (Yang et al., , 2001 (Figure 2B,  ⌬cpp1) . In clear contrast, the cpp1-v1 mutant cells displayed cylindrical cell shape ( Figure 2B, cpp1-v1) , suggesting that farnesylation of Ras1 in cpp1-v1 mutant cells is not considerably defective so as to affect the cell shape. These results suggest that CAAX-ending Ras1, Rho2, and Rho3 are targets of Cpp1 in fission yeast. More importantly, the partial loss of the farnesyltransferease activity caused by the cpp1-v1 mutation differentially impacts the function of these small GTPases.
To investigate whether there is a defect in the farnesylation of these three substrates in cpp1-v1 mutant cells, we constructed FLAG-tagged Rho2, Ras1, and Rho3, and we expressed these in wild-type, cpp1-v1 mutant, and ⌬cpp1 cells. As shown in Figure 2C , Rho2, Ras1, and Rho3 extracted from ⌬cpp1 cells migrated slower (unmodified), compared with those from wild-type cells (prenylated). Rho2, Ras1, and Rho3 extracted from the cpp1-v1 mutant cells exhibited significantly different patterns of migration from the wild-type or ⌬cpp1 cells ( Figure 2C) . Notably, in cpp1-v1 mutant cells, prenylation of Ras1 and Rho2 was severely impaired, whereas that of Rho3 was modestly impaired ( Figure 2C ).
Because our intention is to identify components of the protein kinase C-Pmk1 MAPK signaling by isolating vic mutants, we next investigated whether the knockout cells of the three targets exhibit vic phenotype similar to that of cpp1-v1/vic1-1 cells. Results clearly showed that ⌬rho2 cells, but not ⌬ras1 or ⌬rho3 cells, were able to grow in the presence of FK506 and 0.2M MgCl 2 ( Figure 2D ). These results raise the possibility that Cpp1-Rho2 is involved in the protein kinase C-Pmk1 MAPK signaling. We also examined the morphology of ⌬rho2, ⌬ras1, and ⌬rho3 cells to understand the differential roles of different small GTPases in cellular morphogenesis. ⌬ras1 cells displayed the round cell shape similar to that of ⌬cpp1 cells, whereas neither ⌬rho2 nor ⌬rho3 cells showed obvious defect in morphology ( Figure 2E ).
Farnesylation by Cpp1 Is Essential for the Membrane Localization and Function of Rho2
To examine whether the membrane localization of Rho2 is critical for its function, we created various mutant versions of Rho2 at its C terminus. As shown in Figure 2B and here, wild-type Rho2 (Rho2CIIS) localized to the plasma membrane in wild-type cells, but not in cpp1-v1 mutant or ⌬cpp1 cells ( Figure 3A, GFP-Rho2CIIS) . In contrast, the geranylgeranylated mutant form of Rho2 (Rho2CIIL), which bypasses the farnesylation requirement, localized to the plasma membrane both in wild-type cells and in cpp1 mutant cells, indicating that geranylgeranylation allows Rho2 to associate with the membrane even in the absence of farnesylation ( Figure 3A , GFP-Rho2CIIL). However, the prenylation-defective Rho2 (Rho2SIIS), wherein the cysteine in the CAAX-motif was replaced with serine, failed to localize to the plasma membrane even in wild-type cells ( Figure 3A , GFP-Rho2SIIS).
Notably, Rho2CIIL, which localized to the plasma membrane, fully suppressed the temperature-sensitive and vic phenotypes of ⌬rho2 cells, suggesting that geranylgeranylated Rho2, which bypasses farnesylation, can function as well as farnesylated Rho2 (Figure 3B, ϩRho2CIIL) . On the other hand, Rho2SIIS, which failed to localize to the plasma membrane, could not suppress the phenotypes ( Figure 3B,  ϩRho2CIIS) , suggesting that the plasma membrane localization of Rho2 is critical for its function.
To address whether the vic phenotype of cpp1-v1 mutant cells is because of the defective farnesylation of Rho2, we overexpressed these mutant forms of Rho2 in cpp1-v1 mutant cells. As expected, only Rho2CIIL, which can localize to the plasma membrane even in cpp1-v1 mutant cells, reversed the vic phenotype of cpp1-v1 mutant cells, whereas Rho2CIIS and Rho2SIIS could not ( Figure 3C ). Thus, Rho2 is the target of Cpp1, that is responsible for the vic phenotype of cpp1-v1 mutant cells, strongly suggesting that Cpp1 functions in Pmk1 MAPK signaling through Rho2 regulation.
Cpp1 and Rho2 Act Upstream of the Pck2-Pmk1 MAPK Pathway
As a first step to examine the functional relationship between Cpp1-Rho2 and Pmk1 signaling, we examined whether the vic phenotype is a specific indication for Pmk1 MAPK signaling, or whether it is shared by other MAPK pathways in fission yeast. For this, null cells of sty1 ϩ encoding a stress-activated MAPK or spk1 ϩ encoding a MAPK involved in meiosis was compared with rho2 null cells, cpp1 mutant cells, together with null cells of the components of the Pmk1 MAPK pathway. Results clearly showed that ⌬rho2, cpp1 mutant cells, as well as ⌬pmk1, ⌬pek1, ⌬mkh1, or ⌬pck2 grew in the presence of FK506 and 0.15M MgCl 2 , but ⌬sty1 or ⌬spk1 could not grow ( Figure 4A , ϩFK506 ϩ 0.15M MgCl 2 ), indicating that the vic phenotype is specifically shared by the mutations in the components of the protein kinase C-Pmk1 MAPK signaling pathway.
Because mutations that perturb the signaling through the protein kinase C-Pmk1 MAPK pathway are known to result in defective cell integrity (Toda et al., 1996) , we examined whether knockout of the components of the protein kinase C-Pmk1 MAPK signaling pathway display hypersensitivity to the cell wall-damaging agent micafungin, an inhibitor of (1,3)-␤-d-glucan synthase (Carver, 2004) . The ⌬rho2, ⌬cpp1 as well as ⌬pck2 or knockout of the components of Pmk1 MAPK pathway were hypersensitive to micafungin, whereas the growth of ⌬sty1 or ⌬spk1 cells was not inhibited in the presence of 1.2 g/ml micafungin ( Figure 4A , top, ϩ 1.2 g/ml micafungin). Thus, the vic phenotype and the sensitivity to micafungin are specific indications of defective protein kinase C-Pmk1 MAPK signaling. Interestingly, ⌬rho3 cells, but not ⌬ras1 cells, displayed hypersensitivity to micafungin ( Figure 4A, bottom) , whereas neither of them showed the vic phenotype ( Figure 2D ).
We next examined whether Rho2 acts upstream of the protein kinase C-Pmk1 MAPK signaling. As reported by Figure 4 (cont) . harboring pREP1-GFP-Pck2 were dropped onto the plate as indicated and then incubated as in Figure 4B . (D) Rho2 stimulates the phosphorylation of Pmk1 in vivo. Wild-type cells containing pREP42-GST-Pmk1 and either pREP1-vector (ϩvector), pREP1-pek1 DD (ϩPek1 DD ), pREP1-Pck2 (ϩPck2), pREP1-Rho2 (ϩRho2), pREP1-Pck1 (ϩPck1), pREP1-Ras1 (ϩRas1), or pREP1-Rho3 (ϩRho3) were grown in EMM. Immunoblotting using antiphospho Pmk1 (top) and anti-GST (bottom) antibodies showed that overproduction of Pek1 DD , Pck2 as well as Rho2 but not that of Pck1 increased the levels of phosphorylation of Pmk1. (E) ⌬rho2⌬mkh1, ⌬rho2⌬pek1, ⌬rho2⌬pmk1, or ⌬rho2⌬pck2 double mutants did not show synergism in the sensitivity to micafungin. The cells as indicated were dropped onto the plate as indicated and then incubated as in Figure 4B . (F) Pck2 associates with Mkh1. Cells integrated with GFP-Pck2 were transformed with the control GST vector or pREP1-GST-Mkh1 and then grown in EMM medium in the absence of thiamine for 20 h. GST-Mkh1 and GST were precipitated by glutathione beads, washed extensively, and subjected to SDS-PAGE and immunoblotted using anti-GFP or anti-GST antibodies. Calonge et al. (2000) and as shown here (Figure 4B ), overexpression of Rho2 is toxic to wild-type cells, but not to ⌬pck2 cells. If the toxicity of Rho2 overexpression is caused by the hyperactivation of Pmk1 MAPK pathway, it would be expected that this toxicity could be complemented by knockout of the components of Pmk1 signaling pathway. As expected, the overexpression of Rho2 was not toxic to ⌬mkh1, ⌬pek1, and ⌬pmk1 cells (Figure 4B ), indicating that the toxicity of Rho2 overexpression is mediated by Pck2 and Mkh1-Pek1-Pmk1 signaling pathway. Similarly, overexpression of Pck2 caused the lethality in wild-type cells, but not in ⌬mkh1, ⌬pek1 and ⌬pmk1 cells (Figure 4C ), indicating that the lethality caused by Pck2 overexpression is mediated by Mkh1-Pek1-Pmk1 signaling. Together, these genetic analyses strongly suggest that Rho2 functions upstream of Pck2-Mkh1-Pek1-Pmk1 signaling.
To further confirm that Rho2-Pck2 activates and transmits signaling to Pmk1, we examined the effects of Rho2, Pck2, or Pck1 overexpression on the phosphorylation levels of Pmk1 MAPK by using anti-phospho Pmk1 antibodies (Sugiura et al., 1999) . As shown in Figure 4D , overexpression of Rho2 and Pck2 dramatically increased the phosphorylation levels of Pmk1 similar to that obtained from the overexpression of Pek1 DD , a constitutively active MAPKK for Pmk1 ( Figure  4D ). In clear contrast, overexpression of Pck1 did not increase the phosphorylation level of Pmk1 ( Figure 4D ). Thus, Rho2-Pck2 acts upstream of the Pmk1 MAPK pathway and stimulates the Pmk1 signaling in vivo. In addition, overexpression of Ras1 or Rho3 did not increase the phosphorylation level of Pmk1 ( Figure 4D ). Together with the results of Figures 2D and 4A , this suggests that Rho3 is involved in the regulation of cell wall integrity but independently of the Pmk1 signaling pathway.
Next, we constructed a series of double mutants between ⌬rho2 and knockout of the components of the protein kinase C-Pmk1 MAPK signaling and compared the sensitivity to micafungin with each single mutant. The ⌬rho2 cells showed a relatively weak sensitivity to micafungin, because ⌬rho2 cells grew in the presence of 0.6 g/ml micafungin, wherein ⌬mkh1, ⌬pek1, ⌬pmk1, or ⌬pck2 mutants failed to grow. However, ⌬rho2⌬mkh1, ⌬rho2⌬pek1, ⌬rho2⌬pmk1 or ⌬rho2⌬pck2 double knockout mutant cells failed to grow in the presence of 0.4 g/ml micafungin and do not show synergism in the sensitivity to micafungin compared with the parental single knockout ( Figure 4E) .
The above-mentioned results strongly suggest that Pck2 functions upstream of Pmk1. We thus examined whether Pck2 associates with the MAPKKK Mkh1. For this, we expressed glutathione S-transferase (GST)-fused Mkh1 in strains where GFP-Pck2 is chromosomally integrated. In the GST pull-down assay, GFP-Pck2 associates with GST-Mkh1 but not with control GST vector alone ( Figure 4F ), indicating a protein-protein interaction between Pck2 and Mkh1. Pck1 Is Involved in Cell Integrity Signaling and Acts Independently of the Pmk1 MAPK Pathway In the study by Toda et al. (1993) , Pck1 and Pck2 have been reported to share an overlapping function for cell viability and to partially complement each other. We then examined whether Pck2 and Pck1 share an overlapping function in cell integrity and chloride ion homeostasis.
For this, we first compared ⌬pck1 and ⌬pck2 cells regarding vic phenotype. Results clearly showed that ⌬pck2, but not ⌬pck1, grew in the presence of FK506 and 0.2 M MgCl 2 ( Figure 5A ), suggesting that Pck1 is not involved in Cl Ϫ homeostasis. We also compared ⌬pck1 and ⌬pck2 cells regarding the cell integrity defect. As shown in Figure 5B , at a higher concentration of micafungin (0.6 g/ml), the growth of ⌬pck1 and ⌬pck2 cells were significantly inhibited, but at a lower concentration of micafungin (0.4 g/ml), the growth of ⌬pck2 cells was markedly inhibited compared with that of ⌬pck1 cells. These results indicate that although ⌬pck1 and ⌬pck2 cells are both sensitive to micafungin, ⌬pck1 cells displayed a weaker sensitivity to micafungin compared with ⌬pck2 cells.
As shown in Figure 4D , ⌬rho2⌬pck2 double mutants showed micafungin sensitivity to the same extent as that of ⌬pck2 mutants. Here, we constructed ⌬rho2⌬pck1 double mutants and investigated the micafungin sensitivity. Although both ⌬pck1 cells and ⌬rho2 cells can grow in the presence of 0.4 g/ml micafungin, ⌬rho2⌬pck1 double mutants failed to grow in the presence of 0.4 g/ml micafungin, indicating a synergism in the sensitivity to micafungin compared with that of the parental single knockout ( Figure 5B ). Thus, Pck1 seems to play a role in cell integrity in parallel to the Rho2-Pck2-Mkh1-Pek1-Pmk1 signaling pathway. Consistently, our recent study showed that Pmk1 is required for the stimulation of calcineurin via Yam8/Cch1-mediated Ca 2ϩ influx and that knockout of pck2 ϩ , but not pck1 ϩ gene, markedly diminished the Yam8/Cch1-dependent stimulation of calcineurin activity, suggesting that Pck2 acts upstream of the Pmk1 in this signaling pathway (Deng et al., 2006) . Furthermore, overexpression of pck1 ϩ , but not pck2 ϩ , partially suppressed the micafungin sensitivity of ⌬mkh1 and ⌬pmk1 cells ( Figure 5C ). Overexpression of pck1 ϩ also partially suppressed the micafungin sensitivity of ⌬pek1 cells (our unpublished data). These results indicate that Pck1 stimulates the cell integrity signaling independently of the Pmk1 MAPK pathway, whereas Pck2 exerts its function on cell integrity through the MAPK pathway. In addition, a pull-down experiment demonstrated that Pck1 does not associate with Mkh1 ( Figure 5D ), in clear contrast to the association observed between Pck2 and Mkh1 ( Figure 4F ). These results are in good agreement with the findings obtained with phosphorylation experiments.
DISCUSSION
In the present study, we performed a novel genetic screen that aims to identify new regulators of the Pmk1 signaling, and we identified a missense mutation of the cpp1 ϩ gene encoding FTase. Substitution of a highly conserved aspartic acid to an asparagine residue at the amino acid position 155 resulted in the partial but severe impairment of the FTase activity in cpp1-v1 mutant cells.
Interestingly, the cpp1-v1 mutation caused the differential effects on the function of its substrates. That is, the membrane distribution of Ras1 and Rho2 was apparently abolished but that of Rho3 was still maintained in cpp1-v1 mutant cells, indicating that Rho3 farnesylation is not completely abolished in cpp1-v1 mutant cells. This is in good correlation with the moderate defect of prenylation as shown in Figure 2C . Furthermore, although Ras1 prenylation was severely impaired in cpp1-v1 mutant cells ( Figure  2C ), the function of Ras1 seemed to be maintained in the cpp1-v1 mutant cells because their cell shape was not so much affected compared with that of ⌬cpp1 cells. In clear contrast, the function of Rho2 seemed to be severely impaired in the cpp1-v1 mutant cells, because the mutant cells showed a clear vic phenotype similar to that of the ⌬rho2 cells. These results suggest that Rho2 function is preferentially sensitive to defect of FTase activity in the cpp1-v1 mutant cells.
Although a numbers of studies showed that functions of Ras proteins depend on its farnesylation, the identities of the relevant farnesylated proteins in human oncogenesis are not fully resolved. FTIs clearly have the potential to inhibit oncogenic Ras signaling, but FTIs are also effective on tumor cell lines that do not contain mutant Ras (Sepp-Lorenzino et al., 1995; End et al., 2001) , suggesting that the pharmacological effects extend outside of the Ras protein . RhoB, a small GTPase of the mammalian Rho family has been suggested as a potential relevant FTI target (Prendergast, 2001; Cox and Der, 2002) . RhoB exists as both farnesylated and geranylgeranylated forms, whereas the highly homologous RhoA and RhoC isoforms are solely geranylgeranylated (Adamson et al., 1992) . Treatment of cells with FTIs causes a loss of farnesylated RhoB and a consequent increase in geranylgeranylated RhoB (Lebowitz et al., 1997) , and these changes in prenylation have been implicated in the antineoplastic responses to FTIs (Liu et al., 2000) .
Given the high degree of conservation of FTase, Ras and Rho proteins as well as its involvement in human oncogenesis, the cpp1-v1 mutant may be a useful model for studying the conserved molecular mechanism of protein farnesylation and the differential effects of FTase inhibition on the various substrates.
In conclusion, the identification and analyses of cpp1-v1 mutant cells have demonstrated for the first time the functional importance of the posttranslational modification of Rho GTPase protein in the activation of cell integrity signaling through protein kinase C-MAPK pathway. Because of the high similarity between the fission yeast and mammalian MAPK pathway, the screen of vic mutants would further provide an excellent opportunity to identify novel components of MAPK cascade and analyze regulatory mechanisms of MAPK signaling in higher eucaryotes.
